Wolff Wiese Magana’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.92K | Sell |
39
-44
| -53% | -$6.68K | ﹤0.01% | 527 |
|
|
2025
Q1 | $12.5K | Sell |
83
-79
| -49% | -$11.9K | 0.01% | 369 |
|
|
2024
Q4 | $29.9K | Hold |
162
| – | – | 0.02% | 248 |
|
|
2024
Q3 | $31.9K | Buy |
+162
| New | +$31.9K | 0.02% | 241 |
|
|
2022
Q4 | – | Sell |
-319
| Closed | -$63K | – | 816 |
|
|
2022
Q3 | $63K | Buy |
319
+20
| +7% | +$3.95K | 0.05% | 208 |
|
|
2022
Q2 | $64K | Buy |
299
+41
| +16% | +$8.78K | 0.05% | 218 |
|
|
2022
Q1 | $73K | Buy |
258
+34
| +15% | +$9.62K | 0.05% | 219 |
|
|
2021
Q4 | $84K | Buy |
224
+121
| +117% | +$45.4K | 0.05% | 219 |
|
|
2021
Q3 | $42K | Buy |
103
+56
| +119% | +$22.8K | 0.03% | 307 |
|
|
2021
Q2 | $18K | Buy |
47
+28
| +147% | +$10.7K | 0.01% | 409 |
|
|
2021
Q1 | $6K | Hold |
19
| – | – | ﹤0.01% | 558 |
|
|
2020
Q4 | $5K | Buy |
+19
| New | +$5K | ﹤0.01% | 527 |
|